COMMUNIQUÉS West-GlobeNewswire

Abivax Provides Operational and Key Program Update
15/07/2024
Abivax Provides Operational and Key Program Update Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) on track to complete enrollment in early Q1 2025 Top-line results [...]
Claritas HealthTech Receives Clearance from Indian Regulator CDSCO for Claritas iPET™ Software in India for Improving Quality and Efficiency of PET-CT & PET-MRI Scans
15/07/2024
BENGALURU, India and LONDON, July 15, 2024 (GLOBE NEWSWIRE) -- Claritas HealthTech Ltd (“Claritas”) , a healthcare technology company specializing in advanced medical image enhancement, reconstruction, and AI solutions [...]
Organic growth of 20% of the revenue as of June 24
15/07/2024
Press release Ecully, July 11, 2023 – 6 p.m. First-half 2023 revenue of €5.4 million (+75%) Continued ramp-up of Distimp products Strong sales growth in Europe In thousands of euros Unaudited data 2023 2022 % change [...]
Croissance organiquedu chiffre d'affaires de 20%
15/07/2024
Communiqué de presse Ecully, le 11 juillet 2023 – 18h Chiffre d’affaires du 1 er semestre 2023 de 5,4 M€ (+ 75%) Poursuite de la montée en puissance des produits Distimp Forte progression des ventes en Europe En [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2024
15/07/2024
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2024
15/07/2024
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024
Second-Quarter and First-Half 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
EssilorLuxottica: Second-Quarter and First-Half 2024 Results Conference Call Invitation
15/07/2024
Second-Quarter and First-Half 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Panthera BioSolutions Launches Pharmaceutical Good Manufacturing Practice (GMP) Foundational Training Course with Dallas College to Advance Workforce Talent Pipeline in North Texas
15/07/2024
DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is proud to announce a strategic partnership between Dallas College and Panthera BioSolutions, a [...]
Teknova Announces Closing of $15.4 Million Private Placement
12/07/2024
HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/07/2024
SAN FRANCISCO, July 12, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
ARCPOINT ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT
12/07/2024
Greenville, South Carolina, July 12, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to announce that it has entered into a debt settlement agreement (the “ Agreement ”) [...]
HealthRecon Connect Successfully Achieves SOC 2 and SOC 3 Compliance
12/07/2024
DALLAS, July 12, 2024 (GLOBE NEWSWIRE) -- HealthRecon Connect, a leading technology enabled revenue cycle management solutions provider to US Healthcare Providers, reaffirmed its commitment to maintaining high standards [...]
MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department
12/07/2024
DALLAS, TEXAS, July 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products [...]
BioSenic S.A. : Transparency notification received from Véronique Pomi
12/07/2024
PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, July 12, 2024, 6pm CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical [...]
BioSenic S.A. : Notification de transparence reçue de la part de Véronique Pomi
12/07/2024
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes Mont-Saint-Guibert, Belgique, le 12 juillet 2024 à 18h00 CEST – BIOSENIC (Euronext [...]
Clene to Present at the Emerging Growth Conference
12/07/2024
SALT LAKE CITY, July 12, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
AMN Healthcare to Hold Second Quarter 2024 Earnings Conference Call on Thursday, August 8, 2024
12/07/2024
DALLAS, July 12, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2024 financial results and third quarter 2024 outlook on Thursday, [...]
SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner
12/07/2024
DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale of QUELIMMUNE ™ -Pediatric to its U.S. license and distribution partner, [...]

Pages